Publications:

A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.

Journal Of Experimental & Clinical Cancer Research : Cr

Li, Meifang M; Yang, Jilong J; Zhang, Lenghe L; Tu, Sanfang S; Zhou, Xuan X; Tan, Ze Z; Zhou, Weijun W; He, Yanjie Y; Li, Yuhua Y

Publication Date: 2019-05-22

Variant appearance in text: EGFR: L679F

PubMed Link: 31118055

Variant Present in the following documents:

• Main text
• 13046_2019_Article_1207.pdf

View BVdb publication page

Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".

Cells

Purba, Endang R ER; Saita, Ei-Ichiro EI; Maruyama, Ichiro N IN

Publication Date: 2017-06-02

Variant appearance in text: EGFR: L679F

PubMed Link: 28574446

Variant Present in the following documents:

• Main text

View BVdb publication page

β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells.

Molecular Biology Of The Cell

Balanis, Nikolas N; Yoshigi, Masaaki M; Wendt, Michael K MK; Schiemann, William P WP; Carlin, Cathleen R CR

Publication Date: 2011-11

Variant appearance in text: EGFR: L679F

PubMed Link: 21937717

Variant Present in the following documents:

• Main text
• 4288.pdf

View BVdb publication page

The juxtamembrane region of the EGF receptor functions as an activation domain.

Molecular Cell

Red Brewer, Monica M; Choi, Sung Hee SH; Alvarado, Diego D; Moravcevic, Katarina K; Pozzi, Ambra A; Lemmon, Mark A MA; Carpenter, Graham G

Publication Date: 2009-06-26

Variant appearance in text: EGFR: L679F

PubMed Link: 19560417

Variant Present in the following documents:

• Main text

View BVdb publication page